de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in the novo Wilson`s disease

MPS-Authors

Schwarz,  J.
Max Planck Institute of Psychiatry, Max Planck Society;

Antonini,  A.
Max Planck Institute of Psychiatry, Max Planck Society;

Kraft,  E.
Max Planck Institute of Psychiatry, Max Planck Society;

Tatsch,  K.
Max Planck Institute of Psychiatry, Max Planck Society;

Vogl,  T.
Max Planck Institute of Psychiatry, Max Planck Society;

Kirsch,  C. M.
Max Planck Institute of Psychiatry, Max Planck Society;

Leenders,  K. L.
Max Planck Institute of Psychiatry, Max Planck Society;

Oertel,  W. H.
Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Schwarz, J., Antonini, A., Kraft, E., Tatsch, K., Vogl, T., Kirsch, C. M., et al. (1994). Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in the novo Wilson`s disease. Neurology, 44, 1079-1082.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-8457-6
Abstract
There is no abstract available